O’Neal Comprehensive Cancer Center announces recipients of cancer-related research grants through the O’Neal Invests Spring 2025 Cycle
The UAB O’Neal Comprehensive Cancer Center is pleased to announce the latest O’Neal Invests grant awards. O’Neal Invests grants fund UAB investigators initiating new cancer-related projects to do key preliminary work to enable competitive extramural applications. Applications for the tenth grant cycle were submitted in fall 2024.
The awardees receiving funding through O’Neal Invests include:
- Rui Lu, Ph.D.
- Department of Medicine
- Division of Hematology & Oncology
- Pre-R01
- Epigenetic Determinants of Menin Inhibitor Response in Acute Myeloid Leukemia
- Julienne Carstens, Ph.D.
- Department of Medicine
- Division of Hematology & Oncology
- Pre-R01
- Functional Impact of EMT in Metastatic Pancreatic Cancer Chemotherapy Resistance
- Zhangli Su, Ph.D.
- Department of Genetics
- Catalyst
- Novel Small RNA Regulators of GBM Treatment Response
There are two O’Neal Invests RFAs per year, in the spring and fall. O’Neal Cancer Center membership is not a requirement to apply, but awardees must become members. The grants are peer-reviewed by a panel of UAB faculty.
In addition to these grants, two additional awards were funded through the generosity of the Breast Cancer Research Foundation. Learn more about them in this blog post.
There are two O’Neal Invests RFAs per year, in the spring and fall. The new RFA for O’Neal Invests applications will be available June 10, 2025.